Currently, progressive policies concerning therapeutic psychedelic use in professional settings are opening up the possibilities for people to start healing from PTSD, anxiety, and depression like never before. 

In these legally approved therapies (e.g. clinical trials and ketamine therapy with a registered practitioner in the U.S.), the patient’s immersive experience is crucial for the treatment’s efficacy, and music often plays an important role as well. That’s where Sound Off® comes in.

During a psychedelic-assisted therapy session, the patient needs to be physically comfortable and fully present for the internal experience — with zero distractions — in order to process any pain or trauma that could come up. Music is used as a guiding tool throughout the experience to  facilitate the patients’ inner journeys and eventually ease them out at the end of the medication’s duration.

Many pain doctors, integrative psychiatrists, functional neurologists, and health practitioners are finding that Sound Off™ noise-isolating headphones are integral in supporting and enhancing the immersive experience of psychedelic-assisted therapy, whether in one-on-one sessions or in group therapy. (Read more about the group experience here.)

During a session, patients enjoy playlists carefully curated by the practitioner. Our headphones’ high-quality, high-fidelity audio and state-of-the-art technology makes it easy for patients to go deep and get the most out of the treatment.

Over the past few years, mental health has been in crisis around the world. MAPS, the Multidisciplinary Association for Psychedelic Studies, works hard to share their breakthrough research, education, and policy work on psychedelic-assisted therapy with healthcare professionals, in hopes that this modality will increasingly be embraced as a mainstream mental-health treatment.

In the US, signs of the acceptance of psychedelic-assisted therapy are definitely emerging. The adult use of psilocybin (a drug showing promise for treating PTSD, depression, and anxiety in the terminally ill) was legalized in Oregon on January 1st of this year. Similarly, health centers focusing on legal psilocybin therapy are planned to open in Colorado in 2024.

As more and more research is documented on the healing effects of professionally administered substances such as cannabis, MDMA, ketamine, and psilocybin on PTSD, addiction, anxiety, depression, and obsessive-compulsive disorder, future progressive policies could continue the expanded reach of psychedelic-assisted therapy to people who need it most. Sound Off is proud to contribute our technology to legally approved therapies in this exciting mental-health field.